This episode features Prathamesh Prabhudasai, co-founder and CEO of SafeBVM, discussing the critical issue of ineffective manual ventilation during resuscitation. We uncover the alarming statistic that up to 50% of patients experience hypoxia due to improper bag-valve mask (BVM) use. SafeBVM addresses this problem with a novel device that works with any commercially available BVM, providing a flow-limiting valve to ensure safer and more effective breaths. Prath also emphasizes the challenges faced by healthcare providers due to infrequent BVM use and high staff turnover, and how SafeBVM’s technology helps maintain competency and improve patient outcomes.

SafeBVM’s approach offers a comprehensive solution that includes training coupled with their optimized manual bag for ventilation. Prath touches on the importance of federal funding in supporting clinical trials and supporting their development journey. Thanks to this foundation, the company has already seen significant success in cities like Colorado Springs and Saint Charles, with positive clinical outcomes and growing adoption. The company is now focusing on scaling, while also preparing to release exciting clinical trial data, be sure to tune in so you can be informed and inspired.

5 Key Takeaways:

• Significant Impact of Ineffective Ventilation: Improper BVM use leads to high rates of hypoxia and negatively impacts patient survival, highlighting the urgent need for improved ventilation techniques.
• SafeBVM’s Innovative Solution: The SafeBVM device provides real-time feedback and a flow-limiting valve, ensuring safer and more effective manual ventilation, addressing both clinical and training challenges.
• Data-Driven Approach and Clinical Validation: SafeBVM is committed to rigorous clinical trials and data collection, with upcoming releases of data demonstrating improved patient outcomes and supporting the device’s effectiveness.
• Strategic Go-to-Market Strategy: The company has successfully transitioned from direct sales to a hybrid model involving strategic distributors and partnerships with BVM manufacturers, facilitating wider adoption.
• Federal Funding and Reimbursement Challenges: Prabhudasai emphasizes the crucial role of federal funding in supporting research and development, while also acknowledging the ongoing challenges related to reimbursement in the EMS sector.